Table 3.
HR | 95% CI | p | ||
---|---|---|---|---|
Lower | Upper | |||
BRAF V600E positivity | 3.82 | 1.04 | 13.97 | 0.043 |
CPSF2 groups <3+ | 4.97 | 1.08 | 22.77 | 0.039 |
Lymphovascular involvement | 1.80 | 0.59 | 5.49 | 0.298 |
Multifocal tumors | 1.13 | 0.34 | 3.80 | 0.840 |
Extracapsular spread present | 1.98 | 0.60 | 6.46 | 0.260 |
Tumor invasion into locoregional tissues | 4.40 | 0.94 | 20.48 | 0.059 |
Metastases—lateral region (ref. value) | 0.434 | |||
Metastases—region VI | 1.87 | 0.37 | 9.59 | 0.451 |
Metastases—skip | 3.35 | 0.50 | 22.22 | 0.211 |
Age (years) | 0.95 | 0.91 | 0.99 | 0.020 |
Occult metastases | 2.83 | 0.59 | 13.56 | 0.192 |